Guardant Health [GH] vs Idexx Laboratories [IDXX] Detailed Stock Comparison

Guardant Health Inc.

NASDAQ
Loading...

Idexx Laboratories, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Guardant Health Inc. wins in 4 metrics, Idexx Laboratories, Inc. wins in 15 metrics, with 0 ties. Idexx Laboratories, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Guardant Health Inc. Idexx Laboratories, Inc. Better
P/E Ratio (TTM) -26.47 42.92 Idexx Laboratories, Inc.
Price-to-Book Ratio -113.87 27.85 Idexx Laboratories, Inc.
Debt-to-Equity Ratio -17.22 60.83 Idexx Laboratories, Inc.
PEG Ratio -2.38 2.41 Idexx Laboratories, Inc.
EV/EBITDA -31.17 31.12 Idexx Laboratories, Inc.
Profit Margin (TTM) -42.39% 24.62% Idexx Laboratories, Inc.
Operating Margin (TTM) -42.91% 29.76% Idexx Laboratories, Inc.
EBITDA Margin (TTM) N/A 29.76% N/A
Return on Equity 419.18% 66.20% Guardant Health Inc.
Return on Assets (TTM) -15.59% 25.59% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $-233.07M $1.04B Idexx Laboratories, Inc.
1-Year Return 167.03% 7.30% Guardant Health Inc.
Price-to-Sales Ratio (TTM) 12.07 10.38 Idexx Laboratories, Inc.
Enterprise Value $12.36B $46.85B Idexx Laboratories, Inc.
EV/Revenue Ratio 12.59 10.89 Idexx Laboratories, Inc.
Gross Profit Margin (TTM) 64.63% 60.35% Guardant Health Inc.
Revenue per Share (TTM) $8 $54 Idexx Laboratories, Inc.
Earnings per Share (Diluted) $-3.32 $13.07 Idexx Laboratories, Inc.
Beta (Stock Volatility) 1.65 1.72 Guardant Health Inc.
Short % of Float 10.93% 2.74% Idexx Laboratories, Inc.

Guardant Health Inc. vs Idexx Laboratories, Inc. Stock Performance Analysis

Loading Price Chart...

GH
IDXX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Guardant Health Inc.-1.37%3.95%36.77%48.91%26.44%27.60%
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Guardant Health Inc.167.03%254.87%9.50%350.75%350.75%350.75%
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%

Performance & Financial Health Analysis: Guardant Health Inc. vs Idexx Laboratories, Inc.

MetricGHIDXX
Market Information
Market Cap i$11.53B$44.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,518,232480,502
90 Day Avg. Volume i2,085,557516,114
Last Close$129.82$570.00
52 Week Range$40.35 - $135.00$506.91 - $769.98
% from 52W High-3.84%-25.97%
All-Time High$181.07 (Feb 08, 2021)$769.98 (Nov 26, 2025)
% from All-Time High-28.30%-25.97%
Growth Metrics
Quarterly Revenue Growth0.39%0.14%
Quarterly Earnings Growth0.39%0.15%
Financial Health
Profit Margin (TTM) i-0.42%0.25%
Operating Margin (TTM) i-0.43%0.30%
Return on Equity (TTM) i4.19%0.66%
Debt to Equity (MRQ) i-17.2260.83
Cash & Liquidity
Book Value per Share (MRQ)$-0.76$20.14
Cash per Share (MRQ)$9.16$2.26
Operating Cash Flow (TTM) i$-184,760,000$1.18B
Levered Free Cash Flow (TTM) i$-88,105,872$790.74M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Guardant Health Inc. vs Idexx Laboratories, Inc.

MetricGH (Apr 24, 2026)IDXX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-26.4742.92
Forward P/E i-129.0834.19
PEG Ratio i-2.382.41
Price to Sales (TTM) i12.0710.38
Price to Book (MRQ) i-113.8727.85
Market Capitalization
Market Capitalization i$11.53B$44.66B
Enterprise Value i$12.36B$46.85B
Enterprise Value Metrics
Enterprise to Revenue i12.5910.89
Enterprise to EBITDA i-31.1731.12
Risk & Other Metrics
Beta i1.651.72
Book Value per Share (MRQ) i$-0.76$20.14

Financial Statements Comparison: Guardant Health Inc. vs Idexx Laboratories, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGH (2025)IDXX (2025)
Revenue/Sales i982.02M4.30B
Cost of Goods Sold i349.01M1.64B
COGS % of Revenue i35.5%38.2%
Gross Profit i633.01M2.66B
Gross Margin i64.5%61.8%
Research & Development i364.19M251.21M
Operating Income (EBIT) i-437.25M1.36B
Operating Margin i-44.5%31.6%
EBITDA i-373.91M1.51B
EBITDA Margin i-38.1%35.0%
Pre-Tax Income i-417.54M1.32B
Pre-Tax Income % of Revenue i-42.5%30.8%
Income Tax i-1.26M264.73M
Income Tax % of Revenue i-0.1%6.2%
Net Income (Profit) i-416.28M1.06B
Profit Margin i-42.4%24.6%

Balance Sheet & Liquidity Metrics

MetricGH (2025)IDXX (2025)
Cash & Equivalents i378.20M180.07M
Total Current Assets i1.47B1.41B
Total Current Assets % of Revenue i149.3%32.9%
Total Current Liabilities i302.73M1.15B
Total Current Liabilities % of Revenue i30.8%26.7%
Long-Term Debt i1.68B475.99M
Long-Term Debt % of Revenue i171.3%11.1%
Total Shareholders Equity i-99.31M1.61B
Retained Earnings i-2.99B6.39B
Retained Earnings % of Revenue i-304.9%148.5%
Property, Plant & Equipment i158.85M123.23M

Cash Flow Statement Comparison

MetricGH (2025)IDXX (2025)
Operating Cash Flow i-230.19M1.17B
Operating Cash Flow % of Revenue i-23.4%27.3%
Capital Expenditures i-48.31M-124.68M
Free Cash Flow i-233.07M1.04B
FCF Margin i-23.7%24.2%
Debt Repayment iN/A-428.39M
Common Stock Repurchase i-45.01M-1.22B

Short Interest & Institutional Ownership Analysis

MetricGHIDXX
Shares Short i13.70M1.91M
Short Ratio i7.503.85
Short % of Float i10.93%2.74%
Shares Outstanding i130.64M79.71M
Float Shares i125.75M78.75M
% Held by Insiders i4.04%0.71%
% Held by Institutions i101.22%96.04%
% Held by Public i-5.26%3.25%

Dividend Analysis & Yield Comparison: Guardant Health Inc. vs Idexx Laboratories, Inc.

MetricGHIDXX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A